BeOne Medicines Ltd. (ONC)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $418k
- Sep 30 · Routine
- Form 4 sales
- 324
- On record
- Form 144 notices
- 141
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeSep 1, 2026 2026
Filed to sell 132 shares ($47k)
Ball Titus B., Officer
No 10b5-1 plan1x usual sizeFiling
- 2 Form 4 saleUnusualSep 1, 2026 same day
Sold 132 shares at $355.86 ($47k)
Ball Titus B., Principal Accounting Officer
No 10b5-1 planSold 100% of holdings ($47k position)0 shares left1x usual sizeFollows a Form 144Filing
- 3 Form 144 noticeNoticeSep 8, 2026 +7 days
Filed to sell 131,370 shares ($47.1M)
Wang Xiaodong, Director, Chair, Scientific Advisory Brd
10b5-1 plan3.1x usual sizeFiling
- 4 Form 4 saleRoutineSep 8, 2026 same day
Sold 38,287 shares at $349.10 ($13.4M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($13.4M position)0 shares left0.9x usual sizeFollows a Form 144Filing
- 5 Form 4 saleRoutineSep 28, 2026 +20 days
Sold 31,028 shares at $364.79 ($11.3M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($11.3M position)0 shares left0.7x usual sizeFollows a Form 144Filing
- 6 Form 144 noticeNoticeSep 30, 2026 +2 days
Filed to sell 1,115 shares ($407k)
Lee Chan Henry, Officer
10b5-1 plan1.2x usual sizeFiling
- 7 Form 4 saleRoutineSep 30, 2026 same day
Sold 1,115 shares at $375.00 ($418k)
Lee Chan Henry, SVP, General Counsel
10b5-1 planSold 100% of holdings ($418k position)0 shares left1.2x usual sizeFollows a Form 144Filing
- 8 Form 144 noticeNoticeNov 19, 2026 +50 days
Filed to sell 2,895 shares ($1.2M)
Lee Chan Henry, Officer
10b5-1 plan3.2x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 465)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2026 | Nov 19, 2026 | Lee Chan Henry | Officer | Form 144 notice | 2,895 | $1.2M | Notice | SEC | |
| Sep 30, 2026 | Oct 2, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 1,115 | $418k | 100.0% | Routine | SEC |
| Sep 30, 2026 | Sep 30, 2026 | Lee Chan Henry | Officer | Form 144 notice | 1,115 | $407k | Notice | SEC | |
| Sep 28, 2026 | Sep 30, 2026 | Wang Xiaodong | Director | Form 4 sale | 31,028 | $11.3M | 100.0% | Routine | SEC |
| Sep 8, 2026 | Sep 10, 2026 | Wang Xiaodong | Director | Form 4 sale | 38,287 | $13.4M | 100.0% | Routine | SEC |
| Sep 8, 2026 | Sep 8, 2026 | Wang Xiaodong | Director, Chair, Scientific Advisory Brd | Form 144 notice | 131,370 | $47.1M | Notice | SEC | |
| Sep 1, 2026 | Sep 3, 2026 | Ball Titus B. | Principal Accounting Officer | Form 4 sale | 132 | $47k | 100.0% | Unusual | SEC |
| Sep 1, 2026 | Sep 1, 2026 | Ball Titus B. | Officer | Form 144 notice | 132 | $47k | Notice | SEC | |
| Aug 25, 2026 | Aug 27, 2026 | Wu Xiaobin | President and COO | Form 4 sale | 280 | $106k | 100.0% | Routine | SEC |
| Aug 25, 2026 | Aug 25, 2026 | Wu Xiaobin | Officer | Form 144 notice | 15,000 | $5.6M | Notice | SEC | |
| Aug 25, 2026 | Aug 25, 2026 | Sanders Corazon (Corsee) D. | Former Director | Form 144 notice | 2,075 | $789k | Notice | SEC | |
| Aug 12, 2026 | Aug 12, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 240,810 | $86.5M | 100.0% | Unusual | SEC |
| Aug 11, 2026 | Aug 13, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 2,666 | $960k | 100.0% | Routine | SEC |
| Aug 11, 2026 | Aug 11, 2026 | Lee Chan Henry | Officer | Form 144 notice | 2,002 | $719k | Notice | SEC | |
| Aug 10, 2026 | Aug 10, 2026 | Oyler John | Director, Officer | Form 144 notice | 240,810 | $83.9M | Notice | SEC | |
| Aug 3, 2026 | Aug 5, 2026 | Rosenberg Aaron | Chief Financial Officer | Form 4 sale | 1,157 | $362k | 100.0% | Unusual | SEC |
| Aug 3, 2026 | Aug 3, 2026 | Rosenberg Aaron | Officer | Form 144 notice | 1,157 | $362k | Notice | SEC | |
| Jul 30, 2026 | Aug 3, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 1,044 | $338k | 100.0% | Unusual | SEC |
| Jul 30, 2026 | Jul 30, 2026 | Lee Chan Henry | Officer | Form 144 notice | 1,044 | $338k | Notice | SEC | |
| Jul 22, 2026 | Jul 24, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 1,669 | $542k | 100.0% | Routine | SEC |
| Jul 22, 2026 | Jul 22, 2026 | Lee Chan Henry | Officer | Form 144 notice | 2,001 | $638k | Notice | SEC | |
| Jul 21, 2026 | Jul 22, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 109,713 | $34.6M | 100.0% | Unusual | SEC |
| Jul 17, 2026 | Jul 17, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 64,628 | $20.2M | 100.0% | Routine | SEC |
| Jul 16, 2026 | Jul 17, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 283,154 | $89.4M | 100.0% | Unusual | SEC |
| Jul 14, 2026 | Jul 14, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 145,861 | $44.6M | 100.0% | Unusual | SEC |
| Jul 14, 2026 | Jul 14, 2026 | Oyler John | Director, Officer | Form 144 notice | 513,574 | $156M | Notice | SEC | |
| Jul 13, 2026 | Jul 14, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 60,218 | $18.3M | 100.0% | Unusual | SEC |
| Jul 10, 2026 | Jul 10, 2026 | Oyler John | Director, Officer | Form 144 notice | 150,000 | $45.4M | Notice | SEC | |
| Jul 10, 2026 | Jul 10, 2026 | Oyler John | Director, Officer | Form 144 notice | 49,541 | $15M | Notice | SEC | |
| Jul 8, 2026 | Jul 10, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 664 | $201k | 100.0% | Routine | SEC |
| Jun 23, 2026 | Jun 25, 2026 | Wang Lai | President, Global Head of R&D | Form 4 sale | 1,068 | $296k | 100.0% | Unusual | SEC |
| Jun 23, 2026 | Jun 25, 2026 | Wu Xiaobin | President and COO | Form 4 sale | 1,292 | $357k | 100.0% | Unusual | SEC |
| Jun 23, 2026 | Jun 25, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 3,410 | $934k | 100.0% | Unusual | SEC |
| Jun 23, 2026 | Jun 23, 2026 | Wang Lai | Officer | Form 144 notice | 1,068 | $296k | Notice | SEC | |
| Jun 23, 2026 | Jun 23, 2026 | Wu Xiaobin | Officer | Form 144 notice | 1,292 | $357k | Notice | SEC | |
| Jun 23, 2026 | Jun 23, 2026 | Oyler John | Officer, Director | Form 144 notice | 3,410 | $934k | Notice | SEC | |
| Jun 16, 2026 | Jun 18, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 590 | $157k | 100.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 18, 2026 | Wang Lai | President, Global Head of R&D | Form 4 sale | 1,169 | $310k | 100.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 18, 2026 | Wu Xiaobin | President and COO | Form 4 sale | 1,357 | $362k | 100.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 18, 2026 | Oyler John | Chief Executive Officer | Form 4 sale | 3,693 | $981k | 100.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 16, 2026 | Lee Chan Henry | Officer | Form 144 notice | 590 | $157k | Notice | SEC | |
| Jun 16, 2026 | Jun 16, 2026 | Wang Lai | Officer | Form 144 notice | 1,169 | $310k | Notice | SEC | |
| Jun 16, 2026 | Jun 16, 2026 | Wu Xiaobin | Officer | Form 144 notice | 1,357 | $362k | Notice | SEC | |
| Jun 16, 2026 | Jun 16, 2026 | Oyler John | Officer, Director | Form 144 notice | 3,693 | $981k | Notice | SEC | |
| Jun 15, 2026 | Jun 15, 2026 | Sanders Corazon (Corsee) D. | Director | Form 144 notice | 945 | $251k | Notice | SEC | |
| Jun 11, 2026 | Jun 15, 2026 | Rosenberg Aaron | Chief Financial Officer | Form 4 sale | 631 | $163k | 100.0% | Unusual | SEC |
| Jun 11, 2026 | Jun 15, 2026 | Lee Chan Henry | SVP, General Counsel | Form 4 sale | 428 | $110k | 100.0% | Unusual | SEC |
| Jun 11, 2026 | Jun 15, 2026 | Wang Lai | President, Global Head of R&D | Form 4 sale | 756 | $197k | 100.0% | Unusual | SEC |
| Jun 11, 2026 | Jun 15, 2026 | Wu Xiaobin | President and COO | Form 4 sale | 626 | $164k | 100.0% | Unusual | SEC |
| Jun 11, 2026 | Jun 15, 2026 | Ball Titus B. | Principal Accounting Officer | Form 4 sale | 169 | $43k | 100.0% | Unusual | SEC |